Hospital Admission Rates in Patients with COPD Throughout the COVID-19 Pandemic

References

• Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
   PubMed Web of Science ®Google Scholar
• Lisspers K, Larsson K, Johansson G, et al. Economic burden of COPD in a Swedish cohort: the Arctic study. Int J Chron Obstruct Pulmon Dis. 2018;13:275–285. doi:10.2147/COPD.S149633
   PubMed Web of Science ®Google Scholar
• Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:653–661. doi:10.2147/COPD.S34186
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• GOLD (Global Initiative for Chronic Obstructive Lung Disease). Global strategy for prevention, diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 REPORT); 2023. Available from: https://goldcopd.org/wp-content/uploads/2023/03/GOLD-2023-ver-1.3-17Feb2023_WMV.pdf. Accessed May 16, 2023.
   Google Scholar
• Linden D, Guo-Parke H, Coyle PV, et al. Respiratory viral infection: a potential “missing link” in the pathogenesis of COPD. Eur Respir Rev. 2019;28(151):180063. doi:10.1183/16000617.0063-2018
   PubMed Web of Science ®Google Scholar
• Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806–1812. doi:10.1093/cid/cix647
   PubMed Web of Science ®Google Scholar
• Ryan M, Suaya JA, Chapman JD, Stason WB, Shepard DS, Thomas CP. Incidence and cost of pneumonia in older adults with COPD in the United States. PLoS One. 2013;8(10):e75887. doi:10.1371/journal.pone.0075887
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Young D, Coupland C, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106(19):1503–1511. doi:10.1136/heartjnl-2020-317393
   PubMed Web of Science ®Google Scholar
• Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909–923. doi:10.1016/S2213-2600(21)00095-3
   PubMed Web of Science ®Google Scholar
• Karlsson Sundbaum J, Vanfleteren L, Konradsen JR, Nyberg F, Ekberg-Jansson A, Stridsman C. Severe COVID-19 among patients with asthma and COPD: a report from the Swedish National Airway Register. Ther Adv Respir Dis. 2021;15:17534666211049738. doi:10.1177/17534666211049738
   Web of Science ®Google Scholar
• Halpin DMG, Rabe AP, Loke WJ, et al. Epidemiology, healthcare resource utilization, and mortality of asthma and COPD in COVID-19: a systematic literature review and meta-analyses. J Asthma Allergy. 2022;15:811–825. doi:10.2147/JAA.S360985
   PubMed Web of Science ®Google Scholar
• Andreen N, Andersson LM, Sundell N, Gustavsson L, Westin J. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease. Infect Dis. 2022;54(7):508–513. doi:10.1080/23744235.2022.2050422
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One. 2021;16(8):e0255659. doi:10.1371/journal.pone.0255659
   PubMed Web of Science ®Google Scholar
• Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2022;2022:1–16.
   Google Scholar
• Folkhälsomyndigheten (Public Health Organisation of Sweden). Influensasäsongen 2019–2020; 2020. Available from: https://www.folkhalsomyndigheten.se/contentassets/607a64370a29485a8ad1426684ccd4e3/influensasasongen-2019-2020-sasongssammanfattning-final-v3.pdf. Accessed May 22, 2023.
   Google Scholar
• Ludvigsson JF. How Sweden approached the COVID-19 pandemic: summary and commentary on the national commission inquiry. Acta Paediatr. 2023;112(1):19–33. doi:10.1111/apa.16535
   PubMed Web of Science ®Google Scholar
• Vanfleteren L, Lindberg A, Zhou C, Nyberg F, Stridsman C. Exacerbation risk and mortality in COPD GOLD group A and B patients with and without exacerbation history. Am J Respir Crit Care Med. 2023;208(2):163–175. doi:10.1164/rccm.202209-1774OC
   PubMed Web of Science ®Google Scholar
• Milos Nymberg V, Ellegård LM, Kjellsson G, et al. Trends in remote health care consumption in Sweden: comparison before and during the first wave of the COVID-19 pandemic. JMIR Hum Factors. 2022;9(1):e33034. doi:10.2196/33034
   PubMedGoogle Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. doi:10.1186/1471-2458-11-450
   PubMed Web of Science ®Google Scholar
• Huh K, Kim YE, Ji W, et al. Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study. Thorax. 2021;76(9):939–941. doi:10.1136/thoraxjnl-2020-216526
   PubMed Web of Science ®Google Scholar
• Chan KPF, Ma TF, Kwok WC, et al. Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respir Med. 2020;171:106085. doi:10.1016/j.rmed.2020.106085
   PubMed Web of Science ®Google Scholar
• Tan JY, Conceicao EP, Wee LE, Sim XYJ, Venkatachalam I. COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax. 2021;76(5):512–513. doi:10.1136/thoraxjnl-2020-216083
   PubMed Web of Science ®Google Scholar
• Saeed MI, Sivapalan P, Eklof J, et al. Social distancing in relation to severe exacerbations of chronic obstructive pulmonary disease: a nationwide semi-experimental study during the COVID-19 pandemic. Am J Epidemiol. 2022;191(5):874–885. doi:10.1093/aje/kwab292
   PubMed Web of Science ®Google Scholar
• Alsallakh MA, Sivakumaran S, Kennedy S, et al. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Med. 2021;19(1):124. doi:10.1186/s12916-021-02000-w
   PubMed Web of Science ®Google Scholar
• Poucineau J, Delory T, Lapidus N, et al. Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: a nationwide study in France. Front Med. 2022;9:995016. doi:10.3389/fmed.2022.995016
   Web of Science ®Google Scholar
• Sarc I, Lotric Dolinar A, Morgan T, et al. Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study. Ther Adv Respir Dis. 2022;16:17534666221081047. doi:10.1177/17534666221081047
   Web of Science ®Google Scholar
• So JY, O’Hara NN, Kenaa B, et al. Population decline in COPD admissions during the COVID-19 pandemic associated with lower burden of community respiratory viral infections. Am J Med. 2021;134(10):1252–1259.e1253.
   PubMed Web of Science ®Google Scholar
• Dahne T, Bauer W, Essig A, et al. The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany. Emerg Microbes Infect. 2021;10(1):1515–1518. doi:10.1080/22221751.2021.1957402
   PubMed Web of Science ®Google Scholar
• Huang C. The COVID-19 pandemic and the incidence of the non-COVID-19 Pneumonia in adults. Front Med. 2021;8:737999. doi:10.3389/fmed.2021.737999
   Web of Science ®Google Scholar
• Folkhälsomyndigheten (Public Health Organisation of Sweden). RSV-säsongen 2021–2022; 2022. Available from: https://www.folkhalsomyndigheten.se/globalassets/statistik-uppfoljning/smittsamma-sjukdomar/veckorapporter-rsv/rsv-sasongen-2021-2022_final_uppdaterat-12-aug.pdf. Accessed November 18, 2022.
   Google Scholar
• van Summeren J, Meijer A, Aspelund G, et al. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill. 2021;26(29):2100639. doi:10.2807/1560-7917.ES.2021.26.29.2100639
   PubMedGoogle Scholar